{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:00:53Z","timestamp":1789563653543,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.apsb.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:28:46Z","timestamp":1623072526000},"page":"3857-3868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms"],"prefix":"10.1016","volume":"11","author":[{"given":"Payal","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Aleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-7895","authenticated-orcid":false,"given":"Xuerong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8298-6245","authenticated-orcid":false,"given":"Stephen","family":"Kogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.05.028_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.05.028_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cld.2007.06.003","article-title":"Causality assessment of drug-induced hepatotoxicity: promises and pitfalls","volume":"11","author":"Shapiro","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.apsb.2021.05.028_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2021.05.028_bib4","series-title":"Drug-induced liver injury. Handbook of experimental pharmacology","first-page":"3","author":"Holt","year":"2010"},{"key":"10.1016\/j.apsb.2021.05.028_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4254\/wjh.v9.i10.491","article-title":"Drug-induced liver injury: do we know everything?.","volume":"9","author":"Alempijevic","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4254\/wjh.v6.i8.601","article-title":"Assessing liver injury associated with antimycotics: concise literature review and clues from data mining of the FAERS database","volume":"6","author":"Raschi","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2125.2003.01969.x","article-title":"The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit","volume":"57","author":"Purkins","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.028_bib8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40264-013-0116-9","article-title":"Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database","volume":"36","author":"Brinker","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.apsb.2021.05.028_bib9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4037\/aacnacc2016953","article-title":"Drug-induced liver injury","volume":"27","author":"Hamilton","year":"2016","journal-title":"AACN Adv Crit Care"},{"key":"10.1016\/j.apsb.2021.05.028_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.27206","article-title":"Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump","volume":"60","author":"Aleo","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.05.028_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acs.chemrestox.9b00262","article-title":"Moving beyond binary predictions of human drug-induced liver injury (DILI) toward contrasting relative risk potential","volume":"33","author":"Aleo","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2021.05.028_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/biology8020032","article-title":"Drug-induced mitochondrial toxicity in the geriatric population: challenges and future directions","volume":"8","author":"Will","year":"2019","journal-title":"Biology"},{"key":"10.1016\/j.apsb.2021.05.028_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mito.2016.10.005","article-title":"Drug induced mitochondrial dysfunction: mechanisms and adverse clinical consequences","volume":"31","author":"Vuda","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.apsb.2021.05.028_bib15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00702-002-0748-x","article-title":"Different toxicological profile of two COMT inhibitors in\u00a0vivo: the role of uncoupling effects","volume":"109","author":"Haasio","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.apsb.2021.05.028_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20170111","article-title":"Biomarkers for mitochondrial energy metabolism diseases","volume":"62","author":"Boenzi","year":"2018","journal-title":"Essays Biochem"},{"key":"10.1016\/j.apsb.2021.05.028_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/hepr.12893","article-title":"Serum markers for mitochondrial dysfunction and cell death are possible predictive indicators for drug-induced liver injury by direct acting antivirals","volume":"48","author":"Kakisaka","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.apsb.2021.05.028_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cpt.178","article-title":"Toxicity of a novel therapeutic agent targeting mitochondrial complex I","volume":"98","author":"Low Wang","year":"2015","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.apsb.2021.05.028_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cpt.160","article-title":"Mitochondria as targets of drug toxicity: lessons from the R118 phase I experience","volume":"98","author":"Brass","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2021.05.028_bib20","doi-asserted-by":"crossref","first-page":"w13080","DOI":"10.4414\/smw.2010.13080","article-title":"Liver injury caused by drugs: an update","volume":"140","author":"Stirnimann","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.apsb.2021.05.028_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.taap.2006.12.013","article-title":"Mitochondrial abnormalities\u2014a link to idiosyncratic drug hepatotoxicity?.","volume":"220","author":"Boelsterli","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.028_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0960327113512860","article-title":"Female gender as a susceptibility factor for drug-induced liver injury","volume":"33","author":"Amacher","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.apsb.2021.05.028_bib23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2217\/bmm.15.59","article-title":"Circulating mitochondrial biomarkers for drug-induced liver injury","volume":"9","author":"Shi","year":"2015","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.apsb.2021.05.028_bib24","first-page":"75","article-title":"Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives","volume":"4","author":"Ramachandran","year":"2018","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.apsb.2021.05.028_bib25","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/hep.24022","article-title":"Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review","volume":"52","author":"Hunt","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.05.028_bib26","first-page":"682","article-title":"Serious adverse drug events reported to the FDA: analysis of the FDA adverse event reporting system 2006\u20132014 database","volume":"24","author":"Sonawane","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.apsb.2021.05.028_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40264-016-0414-0","article-title":"Linking MedDRA\u00ae-coded clinical phenotypes to biological mechanisms by the ontology of adverse events: a pilot study on tyrosine kinase inhibitors","volume":"39","author":"Sarntivijai","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.apsb.2021.05.028_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","article-title":"FDA-approved drug labeling for the study of drug-induced liver injury","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.05.028_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17474124.2018.1383154","article-title":"The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury","volume":"12","author":"Thakkar","year":"2018","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib30","doi-asserted-by":"crossref","first-page":"17311","DOI":"10.1038\/s41598-017-17701-7","article-title":"Development of decision forest models for prediction of drug-induced liver injury in humans using a large set of FDA-approved drugs","volume":"7","author":"Hong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.05.028_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-61779-382-0_4","article-title":"High-throughput analysis of mitochondrial oxygen consumption","volume":"810","author":"Hynes","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2021.05.028_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","article-title":"Evaluation of drugs with specific organ toxicities in organ-specific cell lines","volume":"126","author":"Lin","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/toxsci\/kfs208","article-title":"Palmitate increases the susceptibility of cells to drug-induced toxicity: an in\u00a0vitro method to identify drugs with potential contraindications in patients with metabolic disease","volume":"129","author":"Luo","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","article-title":"Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration","volume":"223","author":"Nadanaciva","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.028_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10863-012-9446-z","article-title":"Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform","volume":"44","author":"Nadanaciva","year":"2012","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.apsb.2021.05.028_bib37","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/138161211796904795","article-title":"New insights in drug-induced mitochondrial toxicity","volume":"17","author":"Nadanaciva","year":"2011","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.apsb.2021.05.028_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2174\/138945011795528985","article-title":"Investigating mitochondrial dysfunction to increase drug safety in the pharmaceutical industry","volume":"12","author":"Nadanaciva","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2021.05.028_bib39","first-page":"706","article-title":"The role of mitochondrial dysfunction and drug safety","volume":"12","author":"Nadanaciva","year":"2009","journal-title":"Idrugs"},{"key":"10.1016\/j.apsb.2021.05.028_bib40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/acs.chemrestox.8b00246","article-title":"Evaluation of in\u00a0vitro mitochondrial toxicity assays and physicochemical properties for prediction of organ toxicity using 228 pharmaceutical drugs","volume":"32","author":"Rana","year":"2019","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2021.05.028_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in\u00a0vitro assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib42","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.bmcl.2014.04.039","article-title":"Chemotypes sensitivity and predictivity of in\u00a0vivo outcomes for cytotoxic assays in THLE and HepG2 cell lines","volume":"24","author":"Shah","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2021.05.028_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/KFS197","article-title":"Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria","volume":"129","author":"Porceddu","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib45","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/003335490912400320","article-title":"OpenEpi: a web-based epidemiologic and statistical calculator for public health","volume":"124","author":"Sullivan","year":"2009","journal-title":"Publ Health Rep"},{"key":"10.1016\/j.apsb.2021.05.028_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/toxsci\/kfn056","article-title":"In\u00a0vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone","volume":"103","author":"Dykens","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","article-title":"The significance of mitochondrial toxicity testing in drug development","volume":"12","author":"Dykens","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.05.028_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0009-2797(01)00161-2","article-title":"Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon","volume":"134","author":"Ulrich","year":"2001","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2021.05.028_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.taap.2008.08.013","article-title":"Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in\u00a0vitro","volume":"233","author":"Dykens","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2021.05.028_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03256796","article-title":"Data mining in drug safety","volume":"24","author":"Deshpande","year":"2010","journal-title":"Pharm Med"},{"key":"10.1016\/j.apsb.2021.05.028_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14740338.4.5.929","article-title":"The role of data mining in pharmacovigilance","volume":"4","author":"Hauben","year":"2005","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.apsb.2021.05.028_bib53","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.7150\/ijms.34629","article-title":"Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database","volume":"16","author":"Shimada","year":"2019","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.apsb.2021.05.028_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5414\/CP202033","article-title":"Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS","volume":"52","author":"Fujimoto","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2021.05.028_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12788\/jcso.0167","article-title":"Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network","volume":"14","author":"Kaur","year":"2016","journal-title":"J Community Support Oncol"},{"key":"10.1016\/j.apsb.2021.05.028_bib56","first-page":"755","article-title":"Evaluation of syncope association with \u03b11-adrenoceptor blockers in males using the FAERS database: impact of concomitant hypertension","volume":"74","author":"Ohyama","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.apsb.2021.05.028_bib57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s40425-019-0754-2","article-title":"Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system","volume":"7","author":"Zhai","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2021.05.028_bib58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/genes8120398","article-title":"The mitochondrial basis of aging and age-related disorders","volume":"8","author":"Srivastava","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2021.05.028_bib59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/138920006778520606","article-title":"Bioactivation and hepatotoxicity of nitroaromatic drugs","volume":"7","author":"Boelsterli","year":"2006","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.apsb.2021.05.028_bib60","first-page":"81","article-title":"Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity","volume":"6","author":"Boelsterli","year":"2003","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.apsb.2021.05.028_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tgh.2019.10.15","article-title":"A retrospective case-controlled cohort study of inpatient drug induced liver injury: the RIDDLE study","volume":"5","author":"Worland","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.05.028_bib62","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/bioinformatics\/bts576","article-title":"Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases","volume":"28","author":"Johnson","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2021.05.028_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11926-012-0307-x","article-title":"Racial and gender disparities among patients with gout","volume":"15","author":"Singh","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.apsb.2021.05.028_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002119","article-title":"Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis","volume":"13","author":"Horton","year":"2016","journal-title":"PLoS Med"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:52:51Z","timestamp":1761929571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2211383521002070"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.05.028","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}